| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | -100.00% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BIXT returned -74.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -71.9% |
| 1 year | -74.6% |
| 5 years | +4162.0% |
| 10 years | -98.7% |
| All-time high | $400.00 (Jun 2010) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BIXT would be worth today ›No. Bioxytran, Inc. has not paid a dividend in the past 12 months.
Bioxytran, Inc. is part of the Healthcare sector.
Bioxytran, Inc. has a market cap of 2.44M USD, based on the latest quote.
